Omega Fund VI, L.P.

Insider Reports History

Entity
Company
Location
888 Boylston St., Suite 1111, Boston, MA
Signature
/s/ Otello Stampacchia, authorized signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Omega Fund VI, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Imago BioSciences, Inc. Former 10% owner Common Stock 3.02M $109M $36.00 Jul 20, 2021 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Common Stock 2.16M $28.5M $13.22 Nov 7, 2023 Direct
Theseus Pharmaceuticals, Inc. Former 10% owner Common Stock 711K $2.17M $3.05 Oct 12, 2021 Direct
Imago BioSciences, Inc. Former 10% owner Series B convertible Preferred Stock 0 Jul 20, 2021 Direct
Imago BioSciences, Inc. Former 10% owner Series C convertible Preferred Stock 0 Jul 20, 2021 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series A convertible preferred stock 0 Nov 7, 2023 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 Nov 7, 2023 Direct
Theseus Pharmaceuticals, Inc. Former 10% owner Series B Preferred Stock 0 Oct 12, 2021 Direct

Insider Reports Filed by Omega Fund VI, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Nov 7, 2023 5 $5M 4 Nov 9, 2023 10%+ Owner
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 12, 2021 3 $3M 4 Oct 14, 2021 Former 10% owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 10%+ Owner
IMGO Imago BioSciences, Inc. Jul 20, 2021 4 $0 4 Jul 20, 2021 Former 10% owner
IMGO Imago BioSciences, Inc. Jul 15, 2021 1 $4M 4 Jul 19, 2021 Former 10% owner
IMGO Imago BioSciences, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 10%+ Owner